Concepedia
Statistics
Publications
227
Citations
24.6K
H-Index
79
Active since
1976
Affiliations
Roche (Italy)(Current)
Intercept Pharmaceuticals (United States)
University of Florence
Biogen (Italy)
National Agency for New Technologies, Energy and Sustainable Economic Development
Luciano Adorini is an author at Roche (Italy) specializing in life sciences, immunology, and inflammation.
Publications per year
1976–2024
1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation
Giuseppe Penna, Luciano Adorini · The Journal of Immunology · 2000 · 1.3K citations
Life Sciences, Immunology, Immunopharmacology +15
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 915 citations
Medicine, Endocrinology, Pharmacology +12
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg et al. · Gut · 2011 · 851 citations
Life Sciences, Immunology, Pharmacology +17
Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures
Claudia Winzler, Patrizia Rovere, María Rescigno et al. · The Journal of Experimental Medicine · 1997 · 840 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouriès, Paola Brescia, Alessandra Silvestri et al. · Journal of Hepatology · 2019 · 655 citations · Full text
Life Sciences, Microbiology, Pharmacology +17
1–5 of 227